Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $567.85 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $337.73 | 19 | $0 (2024) |
| ABBVIE INC. | $106.45 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $41.14 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.66 | 2 | $0 (2024) |
| Tris Pharma Inc | $23.48 | 1 | $0 (2021) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19.39 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.62 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($39.66) |
| 2023 | $218.81 | 10 | Supernus Pharmaceuticals, Inc. ($152.13) |
| 2022 | $25.17 | 2 | Supernus Pharmaceuticals, Inc. ($25.17) |
| 2021 | $208.25 | 14 | Supernus Pharmaceuticals, Inc. ($125.40) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/08/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.45 | General |
| Category: PSYCHOLOGY | ||||||
| 08/25/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $4.41 | General |
| Category: PSYCHOLOGY | ||||||
| 08/12/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $2.61 | General |
| Category: PSYCHOLOGY | ||||||
| 08/09/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $19.56 | General |
| Category: PSYCHOLOGY | ||||||
| 08/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: PSYCHOLOGY | ||||||
About Dr. Michael Swaney, MD
Dr. Michael Swaney, MD is a Child & Adolescent Psychiatry healthcare provider based in Saint Simons Island, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477580801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Swaney, MD has received a total of $567.85 in payments from pharmaceutical and medical device companies, with $115.62 received in 2024. These payments were reported across 31 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($567.85).
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Psychiatry
- Location Saint Simons Island, GA
- Active Since 06/28/2006
- Last Updated 07/21/2022
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1477580801
Products in Payments
- QELBREE (Drug) $302.70
- VRAYLAR (Drug) $106.45
- TRINTELLIX (Drug) $39.66
- Qelbree (Drug) $35.03
- Dyanavel XR (Drug) $23.48
- REXULTI (Drug) $21.38
- ABILIFY MAINTENA (Drug) $19.76
- CAPLYTA (Drug) $19.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.